PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global supply chain solutions provider, today announced the acquisition of Bellwyck Pharma Services (Bellwyck), headquartered in Toronto, Canada. With 25 years of experience, Bellwyck is a leader in primary and secondary packaging and labeling for clinical trial and commercial drug markets. The acquisition will add four GMP-compliant facilities to the PCI network in the U.S., Germany and Canada. With Canada and Germany ranked third and fourth in the world for total number of clinical trials, respectively, this acquisition greatly enhances the global reach of PCI’s services in key markets.
Read the full article: PCI Pharma Services Announces the Acquisition of Bellwyck Pharma Services //
Source: https://www.businesswire.com/news/home/20200211005625/en/PCI-Pharma-Services-Announces-Acquisition-Bellwyck-Pharma